Trial Profile
Phase 4 Study of Randomized Comparison Among Oral Rapamycin [sirolimus] Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Sirolimus (Primary) ; Paclitaxel; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ORAR-III
- 11 Mar 2013 Final 5-year results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 07 Nov 2012 Four-year results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 01 Sep 2012 Three-year results published in Catheterization and Cardiovascular Interventions.